[go: up one dir, main page]

DE69532958D1 - Konjugate aus metallkomplexen und oligonukleotiden - Google Patents

Konjugate aus metallkomplexen und oligonukleotiden

Info

Publication number
DE69532958D1
DE69532958D1 DE69532958T DE69532958T DE69532958D1 DE 69532958 D1 DE69532958 D1 DE 69532958D1 DE 69532958 T DE69532958 T DE 69532958T DE 69532958 T DE69532958 T DE 69532958T DE 69532958 D1 DE69532958 D1 DE 69532958D1
Authority
DE
Germany
Prior art keywords
conjugates
oligonucleotids
oligonucleotides
complex
bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69532958T
Other languages
English (en)
Other versions
DE69532958T2 (de
Inventor
Ludger Dinkelborg
Christoph-Stephan Hilger
Ulrich Niedballa
Johannes Platzek
Bernd Raduechel
Ulrich Speck
Larry Gold
Wolfgang Pieken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Nexstar Pharmaceuticals Inc
Original Assignee
Schering AG
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25938359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69532958(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4424922A external-priority patent/DE4424922A1/de
Priority claimed from DE19944445078 external-priority patent/DE4445078A1/de
Application filed by Schering AG, Nexstar Pharmaceuticals Inc filed Critical Schering AG
Publication of DE69532958D1 publication Critical patent/DE69532958D1/de
Application granted granted Critical
Publication of DE69532958T2 publication Critical patent/DE69532958T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE69532958T 1994-07-14 1995-06-30 Konjugate aus metallkomplexen und oligonukleotiden Expired - Fee Related DE69532958T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4424922A DE4424922A1 (de) 1994-07-14 1994-07-14 Konjugate aus Metallkomplexen und Oligonucleotiden, die spezifisch an bestimmte Zielstrukturen binden
DE4424922 1994-07-14
DE4445078 1994-12-05
DE19944445078 DE4445078A1 (de) 1994-12-05 1994-12-05 Konjugate aus Metallkomplexen und Oligonucleotiden, diese enthaltende Mittel, deren Verwendung in der Radiodiagnostik sowie Verfahren zu deren Herstellung
PCT/EP1995/002539 WO1996002274A1 (en) 1994-07-14 1995-06-30 Conjugates made of metal complexes and oligonucleotides

Publications (2)

Publication Number Publication Date
DE69532958D1 true DE69532958D1 (de) 2004-06-03
DE69532958T2 DE69532958T2 (de) 2009-04-09

Family

ID=25938359

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532958T Expired - Fee Related DE69532958T2 (de) 1994-07-14 1995-06-30 Konjugate aus metallkomplexen und oligonukleotiden

Country Status (23)

Country Link
EP (1) EP0777498B1 (de)
JP (2) JPH10503182A (de)
KR (1) KR100366525B1 (de)
CN (1) CN1219551C (de)
AT (1) ATE265229T1 (de)
AU (1) AU2979195A (de)
CA (1) CA2194558A1 (de)
CZ (1) CZ295930B6 (de)
DE (1) DE69532958T2 (de)
DK (1) DK0777498T3 (de)
ES (1) ES2220933T3 (de)
HU (1) HU220859B1 (de)
IL (1) IL114237A (de)
MX (1) MX9606443A (de)
NO (1) NO318585B1 (de)
NZ (1) NZ289831A (de)
PL (1) PL318147A1 (de)
PT (1) PT777498E (de)
RU (1) RU2165771C2 (de)
SK (1) SK284598B6 (de)
TW (1) TW502040B (de)
UA (1) UA48140C2 (de)
WO (1) WO1996002274A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739391B2 (en) * 1996-07-03 2001-10-11 President And Fellows Of Harvard College Oligonucleotide linker and techniques involving immobilized and linked oligonucleotides
US6335437B1 (en) * 1998-09-07 2002-01-01 Isis Pharmaceuticals, Inc. Methods for the preparation of conjugated oligomers
JP2009535383A (ja) * 2006-05-03 2009-10-01 バルティック テクロノジー デヴェロプメント，リミテッド 強く結合した塩基で修飾されたオリゴヌクレオチドと人工ヌクレアーゼを組み合わせたアンチセンス作用物質
GB201012418D0 (en) * 2010-07-23 2010-09-08 Santaris Pharma As Process
CA2948699C (en) 2014-05-13 2019-11-26 Paul Scherrer Institut Production of 43sc radionuclide and radiopharmaceuticals thereof for use in positron emission tomography

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013831A (en) * 1984-01-30 1991-05-07 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
JP2785025B2 (ja) * 1985-03-19 1998-08-13 ランデル・エル・ミルズ 診断と選択的組織壊死を与える装置
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
WO1989000062A1 (en) * 1987-07-07 1989-01-12 The Cancer Institute Board Radiotherapy
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
DK0533838T3 (da) * 1990-06-11 1998-02-23 Nexstar Pharmaceuticals Inc Nukleinsyreligander
IE914220A1 (en) * 1990-12-10 1992-06-17 Akzo Nv Labelled, modified oligonucleotides
EP0588229A3 (en) * 1992-09-12 1994-06-15 Hoechst Ag Macrocyclic chelating agents for the preparation of technetium or rhenium complexes

Also Published As

Publication number Publication date
EP0777498A1 (de) 1997-06-11
SK2897A3 (en) 1997-09-10
TW502040B (en) 2002-09-11
ATE265229T1 (de) 2004-05-15
CA2194558A1 (en) 1996-02-01
NZ289831A (en) 1999-01-28
CZ295930B6 (cs) 2005-12-14
NO970141L (no) 1997-03-14
ES2220933T3 (es) 2004-12-16
EP0777498B1 (de) 2004-04-28
NO318585B1 (no) 2005-04-11
PT777498E (pt) 2004-09-30
RU2165771C2 (ru) 2001-04-27
KR100366525B1 (ko) 2003-03-15
SK284598B6 (sk) 2005-07-01
CZ11497A3 (cs) 1998-08-12
DE69532958T2 (de) 2009-04-09
IL114237A0 (en) 1995-10-31
HU220859B1 (en) 2002-06-29
CN1152879A (zh) 1997-06-25
JP2009197024A (ja) 2009-09-03
AU2979195A (en) 1996-02-16
MX9606443A (es) 1997-12-31
IL114237A (en) 2000-08-31
PL318147A1 (en) 1997-05-12
HU9700100D0 (en) 1997-02-28
CN1219551C (zh) 2005-09-21
HUT76329A (en) 1997-08-28
WO1996002274A1 (en) 1996-02-01
JPH10503182A (ja) 1998-03-24
UA48140C2 (uk) 2002-08-15
DK0777498T3 (da) 2004-08-16
KR970704471A (ko) 1997-09-06
NO970141D0 (no) 1997-01-13

Similar Documents

Publication Publication Date Title
ATE228361T1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
ATE473759T1 (de) Bifunktionelle moleküle sowie darauf basierende therapien.
EP2112165A3 (de) Verfahren und Zusammensetzungen zur Behandlung von Glomerulonephritis und anderen Entzündungskrankheiten
IL158088A (en) Use of an antibody linked to ailim for the preparation of a pharmacological preparation for suppressing or preventing inflammatory bowel disease
DE69507819D1 (de) Hydrocyanierungsverfahren und darin verwendbare katalysatorzusammensetzungen aus nickel und mehrzähnigen phosphiten
CA2334267A1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
TR200101751T2 (tr) Poliol-IFN-beta konjugatları
DK1242115T3 (da) Kemisk programmerbar immunitet
IL132156A0 (en) Neoglycoproteins
DE50102815D1 (de) Neue n-phenylpyrrolbisphosphanverbindungen und deren metallkomplexe
WO2001076645A3 (en) Targeted agents useful for diagnostic and therapeutic applications
HUT51594A (en) Process for production of celates and their complexes containing ortolizating functional groups, compositions containing such active substances and process for production of conjugates consisting of one complex and linked to it antibody or fragment of antibody
ATE265229T1 (de) Konjugate aus metallkomplexen und oligonukleotiden
WO2000013712A3 (en) Methods and compositions for the prevention or treatment of cancer
MXPA05006306A (es) Agentes de direccionamiento antilinfoma con funciones efectoras y de afinidad enlazados a traves de un reactivo trifuncional.
EP1234585A3 (de) Zusammensetzungen zur Vorbeugung oder Behandlung von Krebs
WO2002038566A3 (en) Carbene porphyrins and carbene porphyrinoids for use in medical diagnosis and treatment
WO1998051792A8 (en) Fac molecules and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NEXSTAR PHARMACEUTICALS, INC., BOULDER, COL., US

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE

Owner name: NEXSTAR PHARMACEUTICALS, INC., BOULDER, COL., US

8339 Ceased/non-payment of the annual fee